Click here for PART II, PART III, and PART IV
Doug Ward is Chief Executive Officer of Personal Genome Diagnostics (PGDx), a Baltimore company empowering the fight against cancer by unlocking actionable information from the human genome. He has more than 25 years of experience within the diagnostic market, including leadership positions at top-tier molecular diagnostics and testing innovators such as Roche, GE Healthcare, Siemens Healthcare Diagnostics and Bayer Diagnostics. He joined PGDx in 2016 to lead the company to its next stage of growth, which is being realized through the development of a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories worldwide.
Connect with Doug on LinkedIn
